Skip to content

Sanara MedTech Inc. SMTI Liabilities held for sale

Liabilities held for sale at other companies

Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$2.86M-42.9%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s liabilities held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s liabilities held for sale?
Sanara MedTech Inc. (SMTI) reported liabilities held for sale of $713.26K in Q1 2026.
What does liabilities held for sale mean?
Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.